OLDER PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES (T2DM) EXPERIENCE MORE DELAYED TREATMENT WITH ORAL ANTIHYPERGLYCEMIC AGENTS COMPARED WITH YOUNGER PATIENTS
Author(s)
Zhang Q1, Rajagopalan S2, Marrett E1, Radican L11Merck, Whitehouse Station, NJ, USA, 2MedData Analytics, Inc., Williamsville, NY, USA
Presentation Documents
OBJECTIVES: This study compared older (≥ 65 yrs) and younger patients with newly diagnosed T2DM, and evaluated factors associated with oral antihyperglycemic agent (OAHA) initiation. METHODS: This retrospective cohort study used U.S. General Electric (GE) Centricity electronic medical record database. Patients aged ≥30 yrs with newly-diagnosed T2DM (January-2003 to December-2005) were included. There was no diabetes diagnosis or treatment within 2 years prior to the first recorded T2DM diagnosis. Medical records 1 year prior to (baseline) and 2 years after (follow-up) diagnosis were extracted. OAHA initiation was estimated based on the first OAHA prescription during follow-up. Multivariable Cox proportional hazards regression model was fitted. Untreated patients were censored at complete 2 years follow-up. RESULTS: Among 10,760 newly diagnosed T2DM patients, 55% were female. Mean age at T2DM diagnosis was 61.3(±12.5), with 4,617 (43%) ≥65 yrs. At baseline, older relative to younger patients had lower HbA1c (6.7% vs. 7.2%, with only 38% vs. 32% attaining HbA1c <7% goal), lower fasting blood glucose (117.9 vs. 132.8 mg/dL) and lower BMI (30.6 vs. 35.2), higher rates of acute myocardial infarction (MI) (2.1% vs. 0.9%), heart failure (5.1% vs. 1.8%), stroke (3.1% vs. 0.8%), and renal disease (17.5% vs. 6.2%), and more co-medications (all p-values <0.05). Within 2 years after T2DM diagnosis, 56% older and 40.5% younger patients (P<0.001) had not received OAHA. Older patients were less likely to be treated than younger patients (adjusted hazard ratio 0.84, p<0.001). Additionally, patients with baseline MI or renal disease were less likely to be treated (p<0.05). Higher BMI or HbA1c at baseline, and heart failure, initiating antihypertensive or lipid lowering drugs after T2DM diagnosis were factors associated with increased likelihood of OAHA treatment (p<0.05). CONCLUSIONS: Older patients with newly diagnosed T2DM had milder hyperglycemia but more comorbidities, and experienced more delayed OAHA therapy than younger patients.
Conference/Value in Health Info
2010-05, ISPOR 2010, Atlanta, GA, USA
Value in Health, Vol. 13, No. 3 (May 2010)
Code
PDB69
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior
Disease
Diabetes/Endocrine/Metabolic Disorders